Verteporfin selectively kills hypoxic glioma cells through iron-binding and increased production of reactive oxygen species
Published 2018 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Verteporfin selectively kills hypoxic glioma cells through iron-binding and increased production of reactive oxygen species
Authors
Keywords
-
Journal
Scientific Reports
Volume 8, Issue 1, Pages -
Publisher
Springer Nature America, Inc
Online
2018-09-19
DOI
10.1038/s41598-018-32727-1
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- YAP Promotes Migration and Invasion of Human Glioma Cells
- (2018) Yu Zhang et al. JOURNAL OF MOLECULAR NEUROSCIENCE
- Prognostication of Survival Outcomes in Patients Diagnosed with Glioblastoma
- (2018) Damir Nizamutdinov et al. World Neurosurgery
- Elevation of YAP promotes the epithelial-mesenchymal transition and tumor aggressiveness in colorectal cancer
- (2017) Hsiang-Hsi Ling et al. EXPERIMENTAL CELL RESEARCH
- Drug repurposing in cancer
- (2017) Linda Sleire et al. PHARMACOLOGICAL RESEARCH
- Verteporfin exhibits YAP-independent anti-proliferative and cytotoxic effects in endometrial cancer cells
- (2017) Venkata Ramesh Dasari et al. Oncotarget
- Verteporfin-induced formation of protein cross-linked oligomers and high molecular weight complexes is mediated by light and leads to cell toxicity
- (2017) Eleni K. Konstantinou et al. Scientific Reports
- Verteporfin inhibits growth of human glioma in vitro without light activation
- (2017) Ahmad Al-Moujahed et al. Scientific Reports
- The 2016 World Health Organization Classification of Tumors of the Central Nervous System: a summary
- (2016) David N. Louis et al. ACTA NEUROPATHOLOGICA
- Redox cycling metals: Pedaling their roles in metabolism and their use in the development of novel therapeutics
- (2016) Danuta S. Kalinowski et al. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH
- Survival in glioblastoma: a review on the impact of treatment modalities
- (2016) P. D. Delgado-López et al. Clinical & Translational Oncology
- Expression and significance of Hippo/YAP signaling in glioma progression
- (2016) Hao Zhang et al. TUMOR BIOLOGY
- Verteporfin, a suppressor of YAP–TEAD complex, presents promising antitumor properties on ovarian cancer
- (2016) Zhengyu Li et al. OncoTargets and Therapy
- Glioblastoma multiforme: Effect of hypoxia and hypoxia inducible factors on therapeutic approaches
- (2016) Wen-Juan Huang et al. Oncology Letters
- Nuclear translocation and activation of YAP by hypoxia contributes to the chemoresistance of SN38 in hepatocellular carcinoma cells
- (2016) Xiao-Yang Dai et al. Oncotarget
- Repurposing metformin for cancer treatment: current clinical studies
- (2016) Young Kwang Chae et al. Oncotarget
- Tumor-selective proteotoxicity of verteporfin inhibits colon cancer progression independently of YAP1
- (2015) Huabing Zhang et al. Science Signaling
- Disease implications of the Hippo/YAP pathway
- (2015) Steven W. Plouffe et al. TRENDS IN MOLECULAR MEDICINE
- HIF-1α and TAZ serve as reciprocal co-activators in human breast cancer cells
- (2015) Lisha Xiang et al. Oncotarget
- Tumor-selective proteotoxicity of verteporfin inhibits colon cancer progression independently of YAP1
- (2015) Huabing Zhang et al. Science Signaling
- Hypoxic conditions differentially regulate TAZ and YAP in cancer cells
- (2014) Libo Yan et al. ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS
- The clinically used photosensitizer Verteporfin (VP) inhibits YAP-TEAD and human retinoblastoma cell growth in vitro without light activation
- (2014) Katarzyna Brodowska et al. EXPERIMENTAL EYE RESEARCH
- Hypoxia regulates Hippo signalling through the SIAH2 ubiquitin E3 ligase
- (2014) Biao Ma et al. NATURE CELL BIOLOGY
- Glioblastoma and Other Malignant Gliomas
- (2013) Antonio Omuro JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Overexpression of YAP and TAZ Is an Independent Predictor of Prognosis in Colorectal Cancer and Related to the Proliferation and Metastasis of Colon Cancer Cells
- (2013) Lijuan Wang et al. PLoS One
- Genetic and pharmacological disruption of the TEAD-YAP complex suppresses the oncogenic activity of YAP
- (2012) Y. Liu-Chittenden et al. GENES & DEVELOPMENT
- The Hippo pathway target, YAP, promotes metastasis through its TEAD-interaction domain
- (2012) J. M. Lamar et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Hypoxia-mediated drug resistance: Novel insights on the functional interaction of HIFs and cell death pathways
- (2011) Nadine Rohwer et al. DRUG RESISTANCE UPDATES
- Yes-Associated Protein 1 Is Widely Expressed in Human Brain Tumors and Promotes Glioblastoma Growth
- (2011) Brent A. Orr et al. JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY
- The Hippo pathway in organ size control, tissue regeneration and stem cell self-renewal
- (2011) Bin Zhao et al. NATURE CELL BIOLOGY
- The Hippo pathway transcriptional co-activator, YAP, is an ovarian cancer oncogene
- (2011) X Zhang et al. ONCOGENE
- Overexpression of yes-associated protein contributes to progression and poor prognosis of non-small-cell lung cancer
- (2010) Yang Wang et al. CANCER SCIENCE
- The Hippo Signaling Pathway in Development and Cancer
- (2010) Duojia Pan DEVELOPMENTAL CELL
- The Hippo-YAP pathway in organ size control and tumorigenesis: an updated version
- (2010) B. Zhao et al. GENES & DEVELOPMENT
- Yes-associated protein is an independent prognostic marker in hepatocellular carcinoma
- (2009) Michelle Z. Xu et al. CANCER
- YAP-dependent induction of amphiregulin identifies a non-cell-autonomous component of the Hippo pathway
- (2009) Jianmin Zhang et al. NATURE CELL BIOLOGY
- Reactivating HIF prolyl hydroxylases under hypoxia results in metabolic catastrophe and cell death
- (2009) D A Tennant et al. ONCOGENE
- Thalidomide for treatment of multiple myeloma: 10 years later
- (2008) A. Palumbo et al. BLOOD
- TEAD mediates YAP-dependent gene induction and growth control
- (2008) B. Zhao et al. GENES & DEVELOPMENT
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now